Dr Castillo on the Rationale for Evaluating Iopofosine I 131 in Waldenström Macroglobulinemia
Jorge J. Castillo, MD, discusses the rationale for evaluating the iopofosine I 131 in Waldenström macroglobulinemia.
Source: onclive.com
Stay updated with breaking news from Clover Wam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jorge J. Castillo, MD, discusses the rationale for evaluating the iopofosine I 131 in Waldenström macroglobulinemia.
Partnership to Provide Key Data on WM Treatment Landscape and Community Clinic Access to Support Iopofosine I 131 Commercialization Strategy...